Aurora Cannabis (ACB) vs Cumberland Pharmaceuticals (CPIX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cumberland Pharmaceuticals (CPIX) has outperformed Aurora Cannabis (ACB) over the past year, gaining 90.2% versus a loss of 27.4%. Over five years, CPIX leads with a +154.7% price change compared with -93.7% for ACB. Aurora Cannabis is the larger company by market cap ($280.5 million vs $104.6 million), about 2.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACB | CPIX |
|---|---|---|
| Share price | $4.43 | $6.98 |
| Market cap | $280.46M | $104.58M |
| 1-day change | -0.67% | +1.31% |
| YTD return | +4.98% | +75.38% |
| 1-year return | -27.38% | +90.19% |
| 5-year return | -93.70% | +154.74% |
| Forward P/E | — | 49.86 |
| EPS (TTM) | $-0.61 | $-0.62 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.67 | $9.28 |
| 52-week low | $2.56 | $1.85 |
| Distance from 52-week high | -33.53% | -24.78% |
| Analyst consensus | buy | — |
| Average volume | 1.36M | 87.71K |
| Shares outstanding | 63.31M | 14.98M |
| Employees | 1,028 | 88 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Aurora Cannabis is about 2.7 times larger than Cumberland Pharmaceuticals by market value ($280.46M vs $104.58M).
- CPIX has outperformed ACB by 117.6 percentage points over the past year.
About Aurora Cannabis
ACB stock →Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products.
Healthcare · Drug Manufacturers - Specialty & Generic · 1,028 employees
About Cumberland Pharmaceuticals
CPIX stock →Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients receiving chemotherapy treatment; Vaprisol, an injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Vibativ, an injection for the treatment of certain bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections; and Tacilia, an oral capsule for the treatment of H.
Healthcare · Drug Manufacturers - Specialty & Generic · 88 employees
ACB vs CPIX FAQ
Which is bigger, Aurora Cannabis or Cumberland Pharmaceuticals?
Aurora Cannabis (ACB) is larger, with a market capitalization of $280.46M compared with $104.58M for Cumberland Pharmaceuticals (CPIX).
Which stock has performed better over the past year, ACB or CPIX?
CPIX returned +90.19% over the past 12 months, compared with -27.38% for ACB (price return, excluding dividends). Past performance does not predict future results.
Are Aurora Cannabis and Cumberland Pharmaceuticals in the same industry?
Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.